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Introduction: Total vitamin B12 levels decrease significantly during pregnancy and 
recover to normal values within 8- week postpartum. Holotranscobalamin (holoTC) re-
flects the active part of vitamin B12 and has been shown to remain constant during 
pregnancy and postpartum. A mechanism of redistribution of vitamin B12 is sug-
gested, with a shift toward holoTC if there is insufficient total vitamin B12 available. 
Our objective was to examine vitamin B12 deficiency and the active vitamin B12 frac-
tion in postpartum women.
Methods: Total vitamin B12 and holoTC were measured in 171 women within 48 hours 
(T0) and at 5 weeks (T5) postpartum. Vitamin B12 deficiency was defined as total vita-
min B12 < 180 pmol/L or holoTC <32 pmol/L. The active vitamin B12 fraction was 
defined as holoTC/total vitamin B12.
Results: Without intervention, vitamin B12 deficiency based on both serum total vita-
min B12 and holoTC changed from 75% and 60%, to respectively 10% and 6% at T5. 
The fraction of active vitamin B12 was significant higher in vitamin B12 deficient 
women at both time points and across time (P < .0001 and P = .002). A high fraction of 
active vitamin B12 was only present in women with total vitamin B12 deficiency at T0. 
At T5, no high vitamin B12 fraction was found.
Conclusion: The changes in total vitamin B12 levels seem to be based on a physiologi-
cal changes rather than vitamin B12 deficiency. The results of this study confirm the 
hypothesis that a shift toward the metabolic active vitamin B12 (holoTC) occurs in 
women with insufficient available total vitamin B12.
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1  | INTRODUCTION
Serum vitamin B12 (cobalamin) concentrations show a significant de-
crease in each trimester during pregnancy to marginal or nonpregnant 
deficient values in healthy pregnant women.1-4 Postpartum, vitamin 
B12 concentrations spontaneously recover to preconceptional val-
ues.3,5,6 However, serum vitamin B12 measurement has a low posi-
tive predictive value, meaning that a low serum vitamin B12 level 
does not always indicate an actual vitamin B12 deficiency at tissue 
level.7 Therefore, supplementation of vitamin B12 in the absence 
of manifestations of deficiency is a matter of debate in the current 
literature.7,8
Several studies conclude that the observed change of serum vita-
min B12 during pregnancy and postpartum is physiologic.2,3 Despite 
depressed vitamin B12 concentrations, homocysteine, and methylma-
lonic acid levels were not elevated as would be expected in vitamin 
B12 deficiency.1-3,5,6,9 Also, a concomitant increase in erythrocyte co-
balamin was observed.2 Explanations for the cobalamin reduction are 
hemodilution, transportation to the fetus, and redistribution of cobal-
amin. However, serum vitamin B12 concentrations during pregnancy 
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decline more than can be accounted for by hemodilution.9 Also, the 
total requirement of the fetus during pregnancy is estimated to be 
50 μg, while maternal stores in women with mixed diet are estimated 
at >1000 μg.10 Therefore, in well- nourished women, body stores of vi-
tamin B12 are adequate to meet fetal needs during gestation.11 The 
combination of a decrease in total serum vitamin B12, the increase 
in erythrocyte cobalamin, and a decrease in saturation of cobalamin- 
binding serum proteins suggests a redistribution of cobalamin.2
Only 20% of serum vitamin B12 is bound to transcobalamin 
(holoTC), which is the active part of vitamin B12 available for tissue 
uptake.12 The remaining 80% is bound to haptocorrin (holohaptocor-
rin, holoHC) and has no known biological function.6 Several studies 
showed that holoTC remains constant during pregnancy and postpar-
tum,3,5,6 while holoHC decreases during pregnancy.2 Our hypothesis 
is that a shift occurs toward holoTC in women with insufficient avail-
able total vitamin B12. Therefore, the fraction of active vitamin B12 
(holoTC/total vitamin B12) will be higher in women with vitamin B12 
deficiency. Our objectives were to examine the prevalence of vitamin 
B12 deficiency based on total vitamin B12 and holoTC directly and at 
5 weeks postpartum, and to compare the fraction of active vitamin 
B12 between vitamin B12 deficient and not deficient women during 
the first weeks postpartum.
2  | MATERIALS AND METHODS
2.1 | Population
The source population consisted of women who delivered in a large 
teaching hospital in Tilburg, in the southern part of the Netherlands. 
The study was approved by the local ethics committee. All women re-
ceived oral and written information about the study and provided oral 
and written informed consent. Women were eligible for inclusion if 
they were ≥18 years old, thoroughly understood the Dutch language, 
and had indications for blood sampling within 48 hours after delivery, 
including estimated blood loss >500 mL, delivery by cesarean section, 
manual removal of the placenta, and clinical symptoms of anemia. 
Women were excluded if: their hemoglobin was <6.4 g/d (because 
the hospital protocol indicates the need for packed red cell transfu-
sion); they were addicted to alcohol or drugs; they had hematological 
disease, they had chronic inflammatory disease; or they were being 
treated with methotrexate.
2.2 | Laboratory parameters
Maternal venous blood was collected within 48 hours after delivery 
(T0) in the hospital and at 5 weeks postpartum (T5) in the outpatient 
clinic. The women were not informed of their vitamin B12 levels. 
None of the women received vitamin B12 supplementation. If they 
used multivitamins, they were allowed to continue them.
Total vitamin B12 was measured on an Advia Centaur immunoas-
say system (Siemens Healthcare Diagnostics, Breda, the Netherlands). 
HoloTC was measured in each serum sample using an AxSYM immu-
noassay analyzer (Abbott Diagnostics, Hoofddorp, the Netherlands). 
All parameters were measured in control and analyzed in the normal 
diagnostic practice of the laboratory. For the vitamin B12 and holoTC, 
the respective between- run coefficients of variation were 3.1% (target 
value 180 pmol/L) and 4.3% (target value 30 pmol/L).
2.3 | Cutoff values for vitamin B12 and holoTC
Vitamin B12 deficiency was defined as total vitamin B12 < 180 pmol/L 
or holoTC <32 pmol/L.13 The fraction of active vitamin B12 was de-
fined as holoTC/total vitamin B12.14
2.4 | Statistical analyzes
Statistical analyzes were performed using IBM SPSS Statistics 20.0. 
Continuous variables at baseline were compared by independent sam-
ple t tests and nominal variables by Chi- square tests, except holoTC. 
The McNemar test was used to determine the distribution of holoTC 
deficient and not deficient women between the vitamin B12 deficient 
and not deficient women at baseline. Also, the McNemar test was 
used to determine the distribution of vitamin B12 and holoTC defi-
ciency from T0 to T5. The independent sample t test was used to de-
termine the difference in fraction of active vitamin B12 between the 
vitamin B12 deficient and not deficient women at T0 and T5. Analysis 
of variance for repeated measures used to compare the change of 
mean fraction of active vitamin B12 over time between vitamin B12- 
deficient and not deficient women at T0. All results were reported as 
the mean ± standard deviation (SD), or percentage (%), as appropriate.
3  | RESULTS
A total of 171 women were included in the study. The demographic 
and clinical characteristics of the participants at baseline are shown 
in Table 1.
Table 2 shows the significant differences in distribution of total vi-
tamin B12 deficiency and holoTC deficiency from T0 to T5 (P < .0001). 
Vitamin B12 deficiency at T0 was prevalent in 75% (n = 129) of the 
women based on total vitamin B12 values, and in 60% (n = 102) of the 
women based on holoTC. At T5, vitamin B12 deficiency remained in 
9.9% (n = 17) based on total vitamin B12 values, and in 5.8% (n = 10) 
based on holoTC. All women with normal vitamin B12 (n = 42, 24.6%) 
and holoTC values (n = 69, 40.4%) on T0, continued to have normal val-
ues on T5.
Total vitamin B12 deficient women had a significant higher fraction 
of active vitamin B12 compared with not deficient women at both T0 
(Figure 1A, P < .0001, mean 0.25 ± SD 0.12, and mean 0.19 ± SD 0.07) 
and T5 (Figure 1B, P < .0001, mean 0.28 ± SD 0.08, and mean 0.21 ± SD 
0.06). A high fraction of active vitamin B 12 (>0.40) was only present in 
women with total vitamin B12 deficiency at T0 (n = 13, Figure 1A). Of 
these, 85% (n = 11) had a normal holoTC level. At T5, no high vitamin B12 
fraction was found (Figure 1B). Women with total vitamin B12 deficiency 
at T0 had a significant higher fraction of active vitamin B12 over time 
compared to women without vitamin B12 deficiency at T0 (P = .002).
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4  | DISCUSSION
The results of the present study show a spontaneous recovery of vita-
min B12 deficiency based on both total vitamin B12 and holoTC from 
delivery to 5 weeks postpartum. The fraction of active vitamin B12 
was significant higher in vitamin B12- deficient women at both time 
points and across time. A high fraction of active vitamin B12 was only 
present in women with total vitamin B12 deficiency at T0. At T5, no 
high vitamin B12 fraction was found. These results confirm the hy-
pothesis that a shift toward the metabolic active vitamin B12 (holoTC) 
occurs, if there is insufficient total vitamin B12 available. Therefore, 
the observed changes of total vitamin B12 during pregnancy and post-
partum should be considered physiological. Earlier studies confirm 
that conclusion, as homocysteine and methylmalonic acid levels were 
not elevated as would be expected in vitamin B12 deficiency, and a 
concomitant increase in erythrocyte cobalamin was observed.1-3,5,6,9
To our knowledge, this is the first study reporting the course of 
serum vitamin B12, holoTC, and fraction of active vitamin B12 in the 
first weeks postpartum. Based on serum total vitamin B12, the preva-
lence of vitamin B12 deficiency in the present study was higher within 
48 hours postpartum compared with the third trimester of pregnancy 
in the current literature (75% vs 35%- 43%).2,3 Therefore, it seems that 
total vitamin B12 levels even decrease from the third trimester of 
pregnancy to immediately postpartum. The prevalence of vitamin B12 
deficiency at 5 weeks postpartum in the present study is considerably 
higher compared with the prevalence as reported in a previous study 
on vitamin B12 deficiency at 8 weeks postpartum (10% vs 3%).3 This 
could be explained by the difference in time of measurement post-
partum. It is expected that the serum vitamin B12 can spontaneously 
improve from 5 to 8 weeks postpartum. The present study showed a 
significant increase of mean holoTC from T0 to T5, which does not cor-
respond to earlier studies which found that holoTC remains constant 
during pregnancy and postpartum.3,5,6 However, these studies mea-
sured holoTC at the third trimester of pregnancy and at 8 weeks post-
partum, and we measured holoTC in the first postpartum weeks. An 
explanation could be that holoTC decreases from the third trimester of 
TABLE  1 Patient demographic and clinical characteristics at 
baseline (T0)
Vitamin 
B12 < 180 pmol/L 
(n = 129)
Vitamin 
B12 ≥ 180 pmol/L 
(n = 42)
Age at entry (years) 30.5 ± 4.6 31.3 ± 3.8
BMI before pregnancy 
(kg/m2)
25.7 ± 5.8 24.8 ± 4.9
Twin pregnancies 2 (1.6) 1 (2.4)
Ethnicity
Caucasian 117 (90.7) 39 (92.9)
Turkish 4 (3.1) 0 (0.0)
African 4 (3.1) 1 (2.4)
Asian 2 (1.6) 1 (2.4)
South American 2 (1.6) 1 (2.4)
Smoking 13 (10.1) 3 (7.1)
Diet
Omnivore 78 (60.5) 27 (64.3)
Vegetarian 4 (3.1) 0 (0.0)
Unknown 47 (36.4) 15 (35.7)
Multivitamin usea 43/101 (42.6) 21/36 (58.3)
Parity at baseline 1.5 ± 0.7 1.3 ± 0.6
Gestational age at 
delivery (weeks)
39.9 ± 1.5 39.5 ± 1.5
Delivery method
Vaginal 53 (41.4) 13 (31.0)
Caesarean section 76 (58.6) 29 (69.0)
Infant birthweight 
(gram)
3510.5 ± 553.5 3435.1 ± 493.2
Infant feeding
Breastfeeding 78 (60.5) 26 (61.9)
Bottle (formula) 
feeding
51 (39.5) 16 (38.1)
Numbers are mean ± SD or number (percentage).
aUnknown multivitamin use, n = 34.
TABLE  2 Distribution of vitamin B12 and holotranscobalamin (holoTC) deficiency within 48 h postpartum (T0) and at 5 wk postpartum (T5)
Vitamin B12 T5
<180 pmol/L ≥180 pmol/L Total
Vitamin B12 T0 <180 pmol/L 17 (9.9) 112 (65.5) 129 (75.4)
≥180 pmol/L 0 (0.0) 42 (24.6) 42 (24.6)
Total 17 (9.9) 154 (90.1) 171 (100.0)
HoloTC T5
<32 pmol/L ≥32 pmol/L Total
HoloTC T0 <32 pmol/L 10 (5.8) 92 (53.8) 102 (59.6)
≥32 pmol/L 0 (0.0) 69 (40.4) 69 (40.4)
Total 10 (5.8) 161 (94.2) 171 (100.0)
Numbers (percentage).
McNemar test: P < .0001.
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pregnancy to directly postpartum and then increases again to normal 
values at 8 weeks postpartum.
4.1 | Strengths and weaknesses
The present study is limited by selection bias. All included women had 
indication for blood sampling based on potential anemia. However, 
earlier studies found no association of hemoglobin level and vitamin 
B12 status during pregnancy and postpartum.2,3 Homocysteine and 
methylmalonic acid levels were not measured to define vitamin B12 
deficiency in the present study. However, earlier studies found no sig-
nificant correlation between homocysteine or methylmalonic acid and 
vitamin B12 deficiency, both during pregnancy and postpartum.3,5,6 
Another limitation of the study is that in 36% of the included women 
the diet is unknown. Women who are vegetarian or vegan are at in-
creased risk of vitamin B12 deficiency.7 Yet, we believe that this has 
not affected our results. The 4 included vegetarian women in the pre-
sent study were vitamin B12 deficient within 48 hours postpartum. 
Without the use of multivitamins, they all reached normal total vita-
min B12 and holoTC values at 5 weeks postpartum (data not shown).
5  | CONCLUSION
The results of the present study confirm the hypothesis that vitamin 
B12 changes postpartum are physiological and that a shift toward the 
metabolic active vitamin B12 (holoTC) occurs in women with insuf-
ficient available total vitamin B12.
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